19 Paul Tudor Jones II Intra-Cellular Therapies Trades
The first Intra-Cellular Therapies trade was made in Q1 2014.
Since then Paul Tudor Jones II bought shares eight more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2024 and Q4 2024.
Avg closing price
Price range
Sold -31.5 Thousand shares
Q4 2024
Avg closing price
$82.27
Price range
$71.19
-
$91.57
Sold 39.3% shares (-20.4 Thousand shares)
Q3 2024
Avg closing price
$75.04
Price range
$67.99
-
$80.84
New holding (+51.9 Thousand shares)
Q2 2024
Avg closing price
$69.36
Price range
$64.76
-
$79.84
Sold -51.6 Thousand shares
Q1 2024
Avg closing price
$68.73
Price range
$64.37
-
$75.65
Increased shares by 42.1% (+15.3 Thousand shares)
Q4 2023
Avg closing price
$57.53
Price range
$46.37
-
$73.65
Sold 13.6% shares (-5.7 Thousand shares)
Q3 2023
Avg closing price
$58.26
Price range
$52.09
-
$64.10
New holding (+42 Thousand shares)
Q2 2023
Avg closing price
$62.31
Price range
$54.67
-
$66.44
Sold -50.2 Thousand shares
Q4 2022
Avg closing price
$50.11
Price range
$44.07
-
$54.45
Increased shares by 167.8% (+31.4 Thousand shares)
Q3 2022